Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

statements that can be identified by terminology such as "potential," "to present," "to show," "to demonstrate," "can," "will," "to explore," "pipeline," or similar expressions, or by express or implied discussions regarding potential new indications or labeling, or potential marketing approvals for the products described in this release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that any of the products or additional indications or labeling described in this release will be submitted for approval or approved for sale in any market. Nor can there be any guarantee that any of these products will achieve any particular levels of revenue in the future. In particular, management's expectations regarding these products could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove inco
'/>"/>
SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
(Date:8/29/2014)... 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop ... New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists will ... that hyperspectral imaging can bring to examination procedures. ... Director of Product Development at ChemImage, will host ...
(Date:8/29/2014)... 2014  In part four of a ... pharmacy as a strategic asset, Mary Baxter, MBA, ... Cardinal Health,s Innovation Delivery Solutions business, discusses how expanding ... hospitals and patients. "Every hospital pharmacist knows ... their job in a value-based healthcare world," Baxter says. ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4
... ROCKVILLE, Md., Oct. 24, 2011 Vanda Pharmaceuticals Inc. ... has named Bob Repella as Senior Vice President, Chief ... has more than 25 years of experience in the ... sales, new product development and commercial operations.   ...
... 24, 2011 Pinnacle Biologics, Inc., a privately held ... an Orphan Drug Designation (ODD) for their product PHOTOFRIN® ... in the treatment of Malignant Pleural Mesothelioma. ... the lining of the lungs. It is a rare, ...
Cached Medicine Technology:Vanda Pharmaceuticals Appoints Chief Commercial Officer 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 2Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 3Pinnacle Biologics Files for Orphan Drug Designation for PHOTOFRIN® in the Treatment of Patients with Malignant Mesothelioma. 4
(Date:8/29/2014)... (HealthDay News) -- The West African Ebola outbreak took a ... an estimated 500 new cases this week -- the biggest ... cases arose in Liberia, the U.N. health agency said, but ... Associated Press reported. "There are serious problems ... the WHO report. "The situation is worsening in Liberia and ...
(Date:8/29/2014)... September yoga month was created by the Yoga Health ... benefits. To support this Ekhart Yoga is offering those ... , This 4 week guided online yoga program is ... yoga regularly from their own home. Led by Esther ... for all levels, and the dynamic classes will help ...
(Date:8/29/2014)... RBS Reputation Management has brought a new ... service is to help those individuals and organizations that are ... Book. The service would push down the ranking of Scam ... fully invisible on Google. , RBS Reputation Management provides ... asked how company can provide guarantee of results with the ...
(Date:8/29/2014)... Last week, the Fed reported an increase ... production rose to 0.4% while manufacturing output progressed to 1.0%. ... largest boost since February this year. Capacity use has increased ... well – an increase that could be attributed to the ... rate, which is a measure of slack across the industries. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Ethane Web ... recently launched a new service named HTML web design. ... based service. Before tailoring the service, Ethane Web Technologies ... other companies. The company has done its best efforts ... and able to deliver outstanding results to clients. ...
Breaking Medicine News(10 mins):Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 2Health News:Biggest Ever Weekly Rise in Ebola Cases, U.N. Agency Says 3Health News:Ekhart Yoga Launches the Yoga Month Challenge 2Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Ethane Web Technologies Launches a New Web Design Service 2
... that the usage of aspirin to prevent heart problem have ... of Pittsburgh Graduate School of Public Health (GSPH) and others ... Medicine. It said that African Americans and diabetics do not ... medical centers of US and Europe measured regular use of ...
... conducted by Jerald Greenberg professor of management and human resources ... that pay cuts resulted in loss of money and sleep ... in different cities in the Northeast. ,In these ... salary by 10%. The author conducted a supervisor training in ...
... Derek Griffiths, Ph.D., professor of geriatric medicine, University of Pittsburgh ... to the reduced activity of the orbitofrontal cortex of the ... recent issue of the Journal of Urology. He studied the ... , He analyzed the brain activity of 6 normal people ...
... was stated that Malaria affects 300 to 500 million people ... leading// cause of illness and death in the sub-Saharan African ... the Uganda Malaria Surveillance Project and Julia Critchley of the ... drugs showed better efficiency when used in the treatment of ...
... the number of breast cancer cases in the UK. As ... with the ductal carcinoma// in situ (DCIS) during 2002. The ... the hormone therapy drugs are capable of preventing the recurrence ... anastrozole are being studied. The DCIS is considered a pre-cancerous ...
... with regard to a ten-year-old plan to scale down the ... and the rich with regard to this however remains unchanged. ... the establishment of 34 networks for providing better treatment. As ... ,Improvements have been made with regard to ...
Cached Medicine News:Health News:Pay Cut Leads To Increased Levels Of Insomnia Among Workers 2Health News:Older Malarial Drugs Vs New Ones 2
Suction catheter with thumb valve, two eyes, whistle tip...
Rubber bronchial coude catheter, X-ray opaque, one eye, whistle tip....
... 200 Corneal Topographer is the result of ... leader in product innovation and value, continues ... diagnostic instrumentation. The CT 200 is faster ... and repeatable results. The CT 200 is ...
... The patented, accurate and proven DGH-KOI ... the patented MOD III or Neumann ... perfect RK/AK knife. Once a fine ... time-tested quality are then blended to ...
Medicine Products: